TransEnterix Receives Regulatory Approval of the Senhance Surgical System in Japan

Register to receive a free U.S. Market Report Suite for Laparoscopic Devices – MedSuite report synopsis and brochure

TransEnterix, Inc., a medical technology company in the laparoscopic devices industry announced that it has received Japanese regulatory approval for the Senhance™ Surgical System on May 28th, 2019. TransEnterix is working to digitize the interface between surgeons and patients to improve minimally invasive hospital procedures.The surgical system has been cleared by the Ministry of Health, Labor and Welfare for procedures in laparoscopy, including general surgery, gynecology and urology. This is the first of its kind to be launched in Japan.

“Regulatory approval in Japan is a pivotal milestone for our company, as Japan is second only to the U.S. as the world’s largest surgical robotics market,” explained Todd M. Pope, president and chief executive officer of TransEnterix. “Japan’s high penetration of laparoscopic surgery coupled with their rapid adoption of robotics and the intense focus on procedure cost creates a considerable market opportunity for Senhance.”

Market Research, provided by iData, on the total U.S. market for laparoscopic devices is valued at over $4.69 billion in 2019. Growth in the overall market was driven primarily by increases in the number of laparoscopic procedures. The development of new products, including 5 mm laparoscopes, deflective tip laparoscopes, and two camera 3D video laparoscopes, is expected to drive unit sales based on their clinical benefits.

“Approval of the Senhance Surgical System for use in laparoscopic procedures in Japan is a major achievement,” said Professor Shigeki Yamaguchi, M.D., Ph.D., Chief of Colorectal Surgery at Saitama Medical University International Medical Center. “As the first hospital in Japan to obtain and utilize the Senhance Surgical System to treat patients, I believe this technology allows surgeons to offer excellent minimally invasive procedures that add precision and visual control while leveraging a familiar laparoscopic approach with minimal additional costs to the health system.”


For Further Information

More on the laparoscopic device market in the U.S. and Europe can be found in a series of reports published by iData Research. The full report suite includes market research data on laparoscopes, access devices, hand instruments, insufflation devices, suction-irrigation devices, direct energy devices, ultrasonic energy devices, hand-assisted devices, closure devices, gastric bands, powered morcellators, and female sterilization devices.

The iData report series on laparoscopic devices covers the U.S. and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxembourg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about laparoscopic device market data, register online or email us at for a U.S Market Report Suite for Laparoscopic Devices brochure and synopsis.

Leave a Reply